One interesting candidate in this context is Cdc25a, which has already been reported to be regulated by miR-16 in an AML subtype (FLT3-ITD AML) and serves as a critical factor for AML development (Sueur et al., 2020). The gene discussed is FLT3; the disease is acute myeloid leukemia.